BHVN Biohaven Pharmaceutical Holding Co Ltd

$15.88

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending —
Expected on —
Report Time: Unknown Release Time
The Whisper Number
—
Consensus Estimate: —
Revenue Estimate: —

Latest Earnings Insight

Updated On 10/6/2025

About Biohaven Pharmaceutical Holding Co Ltd

Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops candidate products targeting neurological diseases and rare disorders in the United States. The company is headquartered in New Haven, Connecticut.

Website: https://www.biohaven.com

Sector
LIFE SCIENCES
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
December
CIK
1935979
Address
215 CHURCH STREET, NEW HAVEN, CT, US
Valuation
Market Cap
$2.08B
P/E Ratio
nan
PEG Ratio
nan
Price to Book
4.91
Performance
EPS
$-9.28
Dividend Yield
—
Profit Margin
0.00%
ROE
-198.80%
Technicals
50D MA
$29.67
200D MA
$39.03
52W High
$55.70
52W Low
$15.79
Fundamentals
Shares Outstanding
102M
Target Price
$61.00
Beta
4.15

BHVN EPS Estimates vs Actual

● Estimated
● Actual

BHVN News & Sentiment

Sep 17, 2025 • Benzinga SOMEWHAT-BULLISH
This Protagonist Therapeutics Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Wednesday - Biohaven ( NYSE:BHVN ) , Avient ( NYSE:AVNT )
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page.
Sep 11, 2025 • Benzinga NEUTRAL
BIOHAVEN FINAL DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Biohaven Investors of the September 12th Deadline to File in the Class Action Lawsuit - Biohaven ( NYSE:BHVN )
Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Biohaven ( BHVN ) To Contact Him Directly To Discuss Their Options
Sep 09, 2025 • Benzinga NEUTRAL
BHVN FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Biohaven Ltd. Investors to Secure Counsel Before Important September 12 Deadline in Securities Class Action - BHVN - Biohaven ( NYSE:BHVN )
NEW YORK, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Biohaven Ltd. BHVN between March 24, 2023 and May 14, 2025, both dates inclusive ( the "Class Period" ) , of the important September 12, 2025 lead ...
Sep 07, 2025 • Benzinga NEUTRAL
Faruqi & Faruqi Reminds Biohaven Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of September 12, 2025 - BHVN - Biohaven ( NYSE:BHVN )
Faruqi & Faruqi, LLP Securities Litigation Partner James ( Josh ) Wilson Encourages Investors Who Suffered Losses In Biohaven To Contact Him Directly To Discuss Their Options
Sep 05, 2025 • Benzinga NEUTRAL
Levi & Korsinsky Reminds Shareholders of a Lead Plaintiff Deadline of September 12, 2025 in Biohaven Ltd. Lawsuit - BHVN - Biohaven ( NYSE:BHVN )
NEW YORK, Sept. 05, 2025 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky, LLP notifies investors in Biohaven Ltd. ( "Biohaven Ltd." or the "Company" ) BHVN of a class action securities lawsuit.
Sep 05, 2025 • Business Insider NEUTRAL
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Biohaven Ltd. ( BHVN ) Investors of September 12, 2025 Deadline
Class Action Lawsuit Alert: Levi & Korsinsky Reminds Biohaven Ltd. (BHVN) Investors of September 12, 2025 Deadline ...
Sentiment Snapshot

Average Sentiment Score:

-0.083
50 articles with scored sentiment

Overall Sentiment:

Neutral

BHVN Reported Earnings

Mar 03, 2025
Dec 31, 2024 (Pre market)
-0.24 Surprise
  • Reported EPS: $-1.71
  • Estimate: $-1.47
  • Whisper: —
  • Surprise %: -16.2%
Nov 13, 2024
Sep 30, 2024 (Pre market)
-0.19 Surprise
  • Reported EPS: $-1.74
  • Estimate: $-1.55
  • Whisper: —
  • Surprise %: -12.2%
Aug 09, 2024
Jun 30, 2024 (Pre market)
-1.8 Surprise
  • Reported EPS: $-3.50
  • Estimate: $-1.70
  • Whisper: —
  • Surprise %: -106.2%
May 09, 2024
Mar 31, 2024 (Post market)
-0.63 Surprise
  • Reported EPS: $-2.20
  • Estimate: $-1.57
  • Whisper: —
  • Surprise %: -40.1%
Feb 29, 2024
Dec 31, 2023 (Post market)
-0.4 Surprise
  • Reported EPS: $-1.81
  • Estimate: $-1.41
  • Whisper: —
  • Surprise %: -28.4%
Nov 14, 2023
Sep 30, 2023 (Post market)
-0.16 Surprise
  • Reported EPS: $-1.50
  • Estimate: $-1.34
  • Whisper: —
  • Surprise %: -11.9%
Jul 31, 2023
Jun 30, 2023 (Pre market)
-0.11 Surprise
  • Reported EPS: $-1.32
  • Estimate: $-1.21
  • Whisper: —
  • Surprise %: -9.1%
May 12, 2023
Mar 31, 2023 (Post market)
0.38 Surprise
  • Reported EPS: $-1.03
  • Estimate: $-1.41
  • Whisper: —
  • Surprise %: 26.9%
Mar 23, 2023
Dec 31, 2022 (Post market)
-2.1 Surprise
  • Reported EPS: $-3.32
  • Estimate: $-1.22
  • Whisper: —
  • Surprise %: -172.1%

Financials